Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Current Taxes (2021)

Mereo BioPharma (MREO) has disclosed Current Taxes for 1 consecutive years, with $2.1 million as the latest value for Q4 2021.

  • On a quarterly basis, Current Taxes changed N/A to $2.1 million in Q4 2021 year-over-year; TTM through Dec 2021 was $2.1 million, a N/A change, with the full-year FY2021 number at $2.1 million, changed N/A from a year prior.
  • Current Taxes was $2.1 million for Q4 2021 at Mereo BioPharma.
  • In the past five years, Current Taxes ranged from a high of $2.1 million in Q4 2021 to a low of $2.1 million in Q4 2021.